how do med spas get semaglutide — ZZ Spa Is Your Med Spa 'Ozempic'

Eli Lilly submitted the orforglipron NDA to the FDA in Q1 2026 following ATTAIN Phase 3 trial data showing 14.7% body weight reduction at 45mg positioning the worlds first oral small molecule GLP-1 receptor agonist for obesity for anticipated FDA approval in late 2026 or 2027

Nonsurgical treatments such as dermal fillers and biostimulators are commonly used to restore structure, improve skin quality and rebuild collagen

Ffrench-Constant RH

Empagliflozin is associated with improvements in liver enzymes potentially consistent with reductions in liver fat: results from randomised trials including the EMPA-REG OUTCOME trial

These medications can also help quiet food noise and reduce cravings

2024 Dec 23;66(1718):201-2 doi:10.58347/tml.2024.1718a Zepbound (tirzepatide) prescribing information